Author Description

Features a comprehensive and up-to-date review of the molecular basis of cancer; cutting-edge insights from genomics, proteomics, and new chemoprevention strategies; coverage of new cytotoxic or cytostatic low-molecular-weight compounds; discussion of new therapeutic monoclonal antibodies; a description of emerging molecular targets and current drugs under development; and multidisciplinary perspective by recognized authorities from across the US and Europe.